Profilaxis postexposición al VIH (PPE) | 26 DIC 18

Cómo actuar ante un caso de exposición al virus VIH

La profilaxis postexposición posible o real (PPE) al VIH es segura y eficaz para prevenir la infección. Es una modalidad preventiva para personas con exposición reciente (dentro de las 72 horas) al virus
Autor/a: Siedner M, Tumarkin E, Bogoch I HIV post-exposure prophylaxis (PEP)
INDICE:  1. Página 1 | 2. Página 1
Página 1

1 Tan DHS, Hull MW, Yoong D, etal. Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. CMAJ 2017; 189:E1448-58. 10.1503/cmaj.170494 29180384

2 Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV–United States, 2016. Morbidity and Mortality Weekly Report. https://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf.

3 Rodger AJ, Cambiano V, Bruun T, etal. PARTNER Study Group. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 2016; 316:171-81. 10.1001/jama.2016.5148 27404185

4 Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: a systematic review. AIDS 2014; 28:1509-19. 10.1097/QAD.0000000000000298 24809629

5 Cresswell F, Waters L, Briggs E, etal . UK guideline for the use of HIV post-exposure prophylaxis following sexual exposure, 2015. Int J STD AIDS 2016; 27:713-38. 10.1177/0956462416641813 27095790

6 World Health Organization. Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: Recommendations for a public health approach: December 2014—supplement to the 2013 consolidated ARV guidelines. 2014. https://www.who.int/hiv/pub/guidelines/ arv2013/arvs2013upplement_dec2014/en/ 7 Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med 2018; 379:979-81. 10.1056/NEJMc1807653 30037297

8 Tokars JI, Marcus R, Culver DH, etal. The CDC Cooperative Needlestick Surveillance Group. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993; 118:913-9. 10.7326/0003-4819-118-12-199306150-00001 8387737

9 Roland ME, Neilands TB, Krone MR, etal . Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis 2005;41: 1507-13. 10.1086/497268 16231265

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024